04104nam 2201081z- 450 991055751270332120220111(CKB)5400000000044428(oapen)https://directory.doabooks.org/handle/20.500.12854/77048(oapen)doab77048(EXLCZ)99540000000004442820202201d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierRadiolabeled Compounds for Diagnosis and Treatment of CancerBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 online resource (262 p.)3-0365-2427-4 3-0365-2426-6 Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.ChemistrybicsscResearch and information: generalbicssc123,124,125,131I-labeled molecules and biomolecules124I-labeled monoclonal antibodies188Re-liposomeAAZTAadrenergic receptoraprepitantbiomoleculesbreastcancercancer imaging and therapycholecystokinin-2 receptorcleavable linkersDPPEpCAMFAPfluorine-18hypopharyngeal cancerimagingimaging pharmaceuticalsimmunoPET imaging pharmaceuticalsiodinekidney uptakelutetium-177microRNAminigastrinmolecular imagingmonoclonal antibodiesn/aneurokinin 1 receptor antagonistneutral endopeptidase (NEP)NGSpeptidesPETPET probesPIBpositron emission tomographypositron emission tomography (PET)PREPproduction processesprostate-specific membrane antigen (PSMA)proteinspyrazolesradioiodinationradioiodine labelingradiolabelingradionuclideradionuclide chelatorsradionuclide therapyradionuclidesradiopharmaceuticalsradiotracerradiotracersrenal brush border enzymesrepeated therapySAscandium-44somatostatin analogsSPECTtarget-specific biomoleculestargeted radiotherapyChemistryResearch and information: generalKumar Krishanedt125816Kumar KrishanothBOOK9910557512703321Radiolabeled Compounds for Diagnosis and Treatment of Cancer3030930UNINA